ID   ACOD_HUMAN              Reviewed;         359 AA.
AC   O00767; B2R5U0; D3DR68; Q16150; Q53GR9; Q5W037; Q5W038; Q6GSS4;
AC   Q96KF6; Q9BS07; Q9Y695;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   06-JUN-2002, sequence version 2.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Acyl-CoA desaturase;
DE            EC=1.14.19.1 {ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797, ECO:0000269|PubMed:18765284};
DE   AltName: Full=Delta(9)-desaturase;
DE            Short=Delta-9 desaturase;
DE   AltName: Full=Fatty acid desaturase;
DE   AltName: Full=Stearoyl-CoA desaturase {ECO:0000303|PubMed:18765284};
DE            Short=hSCD1 {ECO:0000303|PubMed:15907797};
GN   Name=SCD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Al-Jeryan L., McCord A., Pierotti A.R., Craft J.A.;
RT   "Characterization and expression of a stearoyl CoA desaturase from
RT   human liver.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-224.
RC   TISSUE=Brain, Liver, and Skin;
RX   PubMed=10229681; DOI=10.1042/bj3400255;
RA   Zhang L., Ge L., Parimoo S., Stenn K., Prouty S.M.;
RT   "Human stearoyl-CoA desaturase: alternative transcripts generated from
RT   a single gene by usage of tandem polyadenylation sites.";
RL   Biochem. J. 340:255-264(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-224.
RA   Hoshino T., Ohtsu K.;
RT   "Cloning, sequencing and expression of human stearoyl-CoA
RT   desaturase.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-224.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-224.
RC   TISSUE=Mammary gland, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RX   PubMed=11415448; DOI=10.1042/0264-6021:3570183;
RA   Zhang L., Ge L., Tran T., Stenn K., Prouty S.M.;
RT   "Isolation and characterization of the human stearoyl-CoA desaturase
RT   gene promoter: requirement of a conserved CCAAT cis-element.";
RL   Biochem. J. 357:183-193(2001).
RN   [10]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 2-27.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective
RT   labeling of protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-239.
RC   TISSUE=Adipose tissue;
RX   PubMed=7909540; DOI=10.1002/ijc.2910570310;
RA   Li J., Ding S.-F., Habib N.A., Fermor B.F., Wood C.B., Gilmour R.S.;
RT   "Partial characterization of a cDNA for human stearoyl-CoA desaturase
RT   and changes in its mRNA expression in some normal and malignant
RT   tissues.";
RL   Int. J. Cancer 57:348-352(1994).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15907797; DOI=10.1016/j.bbrc.2005.05.013;
RA   Wang J., Yu L., Schmidt R.E., Su C., Huang X., Gould K., Cao G.;
RT   "Characterization of HSCD5, a novel human stearoyl-CoA desaturase
RT   unique to primates.";
RL   Biochem. Biophys. Res. Commun. 332:735-742(2005).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=15610069; DOI=10.1042/BJ20041554;
RA   Zhang S., Yang Y., Shi Y.;
RT   "Characterization of human SCD2, an oligomeric desaturase with
RT   improved stability and enzyme activity by cross-linking in intact
RT   cells.";
RL   Biochem. J. 388:135-142(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND SUBCELLULAR LOCATION.
RX   PubMed=18765284; DOI=10.1016/j.pep.2008.08.002;
RA   Goren M.A., Fox B.G.;
RT   "Wheat germ cell-free translation, purification, and assembly of a
RT   functional human stearoyl-CoA desaturase complex.";
RL   Protein Expr. Purif. 62:171-178(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-198 AND SER-203, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 45-359 IN COMPLEX WITH
RP   STEAROYL-COENZYME A AND ZINC IONS, AND TOPOLOGY.
RX   PubMed=26098317; DOI=10.1038/nsmb.3049;
RA   Wang H., Klein M.G., Zou H., Lane W., Snell G., Levin I., Li K.,
RA   Sang B.C.;
RT   "Crystal structure of human stearoyl-coenzyme A desaturase in complex
RT   with substrate.";
RL   Nat. Struct. Mol. Biol. 22:581-585(2015).
CC   -!- FUNCTION: Stearyl-CoA desaturase that utilizes O(2) and electrons
CC       from reduced cytochrome b5 to introduce the first double bond into
CC       saturated fatty acyl-CoA substrates (PubMed:15907797,
CC       PubMed:18765284). Catalyzes the insertion of a cis double bond at
CC       the delta-9 position into fatty acyl-CoA substrates including
CC       palmitoyl-CoA and stearoyl-CoA (PubMed:15907797, PubMed:18765284).
CC       Gives rise to a mixture of 16:1 and 18:1 unsaturated fatty acids
CC       (PubMed:15610069). Plays an important role in lipid biosynthesis.
CC       Plays an important role in regulating the expression of genes that
CC       are involved in lipogenesis and in regulating mitochondrial fatty
CC       acid oxidation (By similarity). Plays an important role in body
CC       energy homeostasis (By similarity). Contributes to the
CC       biosynthesis of membrane phospholipids, cholesterol esters and
CC       triglycerides (By similarity). {ECO:0000250|UniProtKB:P13516,
CC       ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797,
CC       ECO:0000269|PubMed:18765284}.
CC   -!- CATALYTIC ACTIVITY: Stearoyl-CoA + 2 ferrocytochrome b5 + O(2) + 2
CC       H(+) = oleoyl-CoA + 2 ferricytochrome b5 + 2 H(2)O.
CC       {ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797,
CC       ECO:0000269|PubMed:18765284}.
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000269|PubMed:18765284,
CC         ECO:0000305|PubMed:26098317};
CC       Note=Expected to bind 2 Fe(2+) ions per subunit, instead of the
CC       Zn(2+) ions seen in the 3D-structure.
CC       {ECO:0000305|PubMed:26098317};
CC   -!- SUBUNIT: May self-associate and form homodimers.
CC       {ECO:0000269|PubMed:15610069}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15907797}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18765284, ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in fetal liver, lung and brain.
CC       Highly expressed in adult adipose tissue, and at lower levels in
CC       adult brain and lung. {ECO:0000269|PubMed:15907797}.
CC   -!- DOMAIN: The histidine box domains are involved in binding the
CC       catalytic metal ions. {ECO:0000269|PubMed:26098317}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13647; CAA73998.1; -; mRNA.
DR   EMBL; AF097514; AAD29870.1; -; mRNA.
DR   EMBL; AB032261; BAA93510.1; -; mRNA.
DR   EMBL; AK312312; BAG35237.1; -; mRNA.
DR   EMBL; AK222862; BAD96582.1; -; mRNA.
DR   EMBL; AL139819; CAH72823.1; -; Genomic_DNA.
DR   EMBL; AL139819; CAH72824.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49829.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49830.1; -; Genomic_DNA.
DR   EMBL; BC005807; AAH05807.1; -; mRNA.
DR   EMBL; BC062303; AAH62303.1; -; mRNA.
DR   EMBL; AF320307; AAK54510.1; -; Genomic_DNA.
DR   EMBL; S70284; AAB30631.1; -; mRNA.
DR   CCDS; CCDS7493.1; -.
DR   PIR; I54779; I54779.
DR   RefSeq; NP_005054.3; NM_005063.4.
DR   UniGene; Hs.558396; -.
DR   PDB; 4ZYO; X-ray; 3.25 A; A=45-359.
DR   PDBsum; 4ZYO; -.
DR   ProteinModelPortal; O00767; -.
DR   SMR; O00767; -.
DR   BioGrid; 112225; 16.
DR   IntAct; O00767; 14.
DR   MINT; MINT-2997962; -.
DR   STRING; 9606.ENSP00000359380; -.
DR   BindingDB; O00767; -.
DR   ChEMBL; CHEMBL5555; -.
DR   SwissLipids; SLP:000000465; -.
DR   iPTMnet; O00767; -.
DR   PhosphoSitePlus; O00767; -.
DR   SwissPalm; O00767; -.
DR   BioMuta; SCD; -.
DR   EPD; O00767; -.
DR   MaxQB; O00767; -.
DR   PaxDb; O00767; -.
DR   PeptideAtlas; O00767; -.
DR   PRIDE; O00767; -.
DR   TopDownProteomics; O00767; -.
DR   Ensembl; ENST00000370355; ENSP00000359380; ENSG00000099194.
DR   GeneID; 6319; -.
DR   KEGG; hsa:6319; -.
DR   UCSC; uc001kqy.4; human.
DR   CTD; 6319; -.
DR   DisGeNET; 6319; -.
DR   GeneCards; SCD; -.
DR   H-InvDB; HIX0009123; -.
DR   HGNC; HGNC:10571; SCD.
DR   HPA; HPA012107; -.
DR   HPA; HPA063921; -.
DR   MalaCards; SCD; -.
DR   MIM; 604031; gene.
DR   neXtProt; NX_O00767; -.
DR   OpenTargets; ENSG00000099194; -.
DR   PharmGKB; PA34984; -.
DR   eggNOG; KOG1600; Eukaryota.
DR   eggNOG; COG1398; LUCA.
DR   GeneTree; ENSGT00530000063158; -.
DR   HOVERGEN; HBG003367; -.
DR   InParanoid; O00767; -.
DR   KO; K00507; -.
DR   OMA; LIPTCKF; -.
DR   OrthoDB; EOG091G0B5S; -.
DR   PhylomeDB; O00767; -.
DR   TreeFam; TF313251; -.
DR   BRENDA; 1.14.19.1; 2681.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-75105; Fatty Acyl-CoA Biosynthesis.
DR   SIGNOR; O00767; -.
DR   ChiTaRS; SCD; human.
DR   GeneWiki; Stearoyl-CoA_desaturase-1; -.
DR   GenomeRNAi; 6319; -.
DR   PRO; PR:O00767; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000099194; -.
DR   Genevisible; O00767; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005506; F:iron ion binding; IDA:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0004768; F:stearoyl-CoA 9-desaturase activity; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB.
DR   CDD; cd03505; Delta9-FADS-like; 1.
DR   InterPro; IPR015876; Acyl-CoA_DS.
DR   InterPro; IPR001522; FADS-1_CS.
DR   PANTHER; PTHR11351; PTHR11351; 1.
DR   PRINTS; PR00075; FACDDSATRASE.
DR   PROSITE; PS00476; FATTY_ACID_DESATUR_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Iron; Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    359       Acyl-CoA desaturase.
FT                                /FTId=PRO_0000185395.
FT   TOPO_DOM      1     72       Cytoplasmic.
FT                                {ECO:0000305|PubMed:26098317}.
FT   TRANSMEM     73     93       Helical. {ECO:0000269|PubMed:26098317}.
FT   TOPO_DOM     94     97       Lumenal. {ECO:0000305|PubMed:26098317}.
FT   TRANSMEM     98    118       Helical. {ECO:0000269|PubMed:26098317}.
FT   TOPO_DOM    119    217       Cytoplasmic.
FT                                {ECO:0000305|PubMed:26098317}.
FT   TRANSMEM    218    237       Helical. {ECO:0000269|PubMed:26098317}.
FT   TOPO_DOM    238    241       Lumenal. {ECO:0000305|PubMed:26098317}.
FT   TRANSMEM    242    263       Helical. {ECO:0000269|PubMed:26098317}.
FT   TOPO_DOM    264    359       Cytoplasmic.
FT                                {ECO:0000305|PubMed:26098317}.
FT   MOTIF       120    125       Histidine box-1. {ECO:0000305}.
FT   MOTIF       157    161       Histidine box-2. {ECO:0000305}.
FT   MOTIF       298    302       Histidine box-3. {ECO:0000305}.
FT   METAL       120    120       Iron 1. {ECO:0000305|PubMed:26098317}.
FT   METAL       125    125       Iron 1. {ECO:0000305|PubMed:26098317}.
FT   METAL       157    157       Iron 1. {ECO:0000305|PubMed:26098317}.
FT   METAL       160    160       Iron 2. {ECO:0000305|PubMed:26098317}.
FT   METAL       161    161       Iron 1. {ECO:0000305|PubMed:26098317}.
FT   METAL       269    269       Iron 2. {ECO:0000305|PubMed:26098317}.
FT   METAL       298    298       Iron 2. {ECO:0000305|PubMed:26098317}.
FT   METAL       301    301       Iron 1. {ECO:0000305|PubMed:26098317}.
FT   METAL       302    302       Iron 2. {ECO:0000305|PubMed:26098317}.
FT   BINDING      75     75       Substrate. {ECO:0000269|PubMed:26098317}.
FT   BINDING     148    148       Substrate. {ECO:0000269|PubMed:26098317}.
FT   BINDING     155    155       Substrate. {ECO:0000269|PubMed:26098317}.
FT   BINDING     156    156       Substrate. {ECO:0000269|PubMed:26098317}.
FT   BINDING     188    188       Substrate. {ECO:0000269|PubMed:26098317}.
FT   BINDING     189    189       Substrate. {ECO:0000269|PubMed:26098317}.
FT   BINDING     262    262       Substrate. {ECO:0000269|PubMed:26098317}.
FT   MOD_RES     198    198       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     203    203       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     224    224       M -> L (in dbSNP:rs2234970).
FT                                {ECO:0000269|PubMed:10229681,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_025994.
FT   CONFLICT      5      5       L -> M (in Ref. 11; AAB30631).
FT                                {ECO:0000305}.
FT   CONFLICT      8      8       D -> E (in Ref. 11; AAB30631).
FT                                {ECO:0000305}.
FT   CONFLICT     25     26       SR -> PG (in Ref. 1; CAA73998 and 11;
FT                                AAB30631). {ECO:0000305}.
FT   CONFLICT    237    237       F -> C (in Ref. 11; AAB30631).
FT                                {ECO:0000305}.
FT   CONFLICT    269    269       H -> L (in Ref. 5; BAD96582).
FT                                {ECO:0000305}.
FT   CONFLICT    320    320       T -> N (in Ref. 1; CAA73998).
FT                                {ECO:0000305}.
FT   CONFLICT    326    326       C -> W (in Ref. 1; CAA73998).
FT                                {ECO:0000305}.
FT   CONFLICT    333    333       A -> T (in Ref. 1; CAA73998).
FT                                {ECO:0000305}.
FT   CONFLICT    356    359       Missing (in Ref. 8; AAH05807).
FT                                {ECO:0000305}.
FT   HELIX        57     59       {ECO:0000244|PDB:4ZYO}.
FT   STRAND       63     65       {ECO:0000244|PDB:4ZYO}.
FT   HELIX        73     91       {ECO:0000244|PDB:4ZYO}.
FT   TURN         92     95       {ECO:0000244|PDB:4ZYO}.
FT   HELIX        98    115       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       116    124       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       132    144       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       150    162       {ECO:0000244|PDB:4ZYO}.
FT   TURN        163    165       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       173    175       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       177    181       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       183    185       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       192    196       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       203    206       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       209    216       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       218    226       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       228    237       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       242    247       {ECO:0000244|PDB:4ZYO}.
FT   TURN        248    250       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       251    262       {ECO:0000244|PDB:4ZYO}.
FT   TURN        263    266       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       267    269       {ECO:0000244|PDB:4ZYO}.
FT   STRAND      271    273       {ECO:0000244|PDB:4ZYO}.
FT   STRAND      278    280       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       286    291       {ECO:0000244|PDB:4ZYO}.
FT   STRAND      292    294       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       298    303       {ECO:0000244|PDB:4ZYO}.
FT   STRAND      308    313       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       319    329       {ECO:0000244|PDB:4ZYO}.
FT   HELIX       341    346       {ECO:0000244|PDB:4ZYO}.
SQ   SEQUENCE   359 AA;  41523 MW;  ED56A63DBD850F05 CRC64;
     MPAHLLQDDI SSSYTTTTTI TAPPSRVLQN GGDKLETMPL YLEDDIRPDI KDDIYDPTYK
     DKEGPSPKVE YVWRNIILMS LLHLGALYGI TLIPTCKFYT WLWGVFYYFV SALGITAGAH
     RLWSHRSYKA RLPLRLFLII ANTMAFQNDV YEWARDHRAH HKFSETHADP HNSRRGFFFS
     HVGWLLVRKH PAVKEKGSTL DLSDLEAEKL VMFQRRYYKP GLLMMCFILP TLVPWYFWGE
     TFQNSVFVAT FLRYAVVLNA TWLVNSAAHL FGYRPYDKNI SPRENILVSL GAVGEGFHNY
     HHSFPYDYSA SEYRWHINFT TFFIDCMAAL GLAYDRKKVS KAAILARIKR TGDGNYKSG
//
